Venezolana. Aveces escribo, aunque la mayoría del tiempo estoy citando :) .
por ahi
Joined August 2009
- Tweets39.4K
- Following582
- Followers777
- Likes562
Pinned Tweet
Me he convertido en un envase contenedor de despedidas, de últimos abrazos y de sueños. Y así, la vida... – at Legnago, Veneto
2
Nagüeboná, acabo de ver Diosdado Cabello como trending topic y dije dios mío escuchaste mis plegarias lo agarraron. Y no... Solo es el hijo de puta demostrándonos que su hijo'e'putes no tiene límites.
1
44
Fabiola Valentina retweeted
Today, we are informing patients and health care providers of a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with use of GLP-1 RA medications.
NAION is a rare condition that can result in acute, painless, decreased vision in one eye, including permanent vision loss. Symptoms of NAION include sudden, painless vision loss in one eye that patients may notice upon waking: visual defects such as blind spots, distortion of colors, blurriness, or tunnel vision.
Patients should contact their health care professional right away if they have any of these symptoms. fda.gov/drugs/drug-safety-co…
ALT A green background features the words "Drug Safety Communication" in bold white and dark blue text. Below are outlined images of medical items, including bottles, a nasal spray, a syringe, tablets, and a blister pack. The FDA logo is in the top right corner.
Me parece una locura y completa irresponsabilidad como se empezó a recetar y suministrar este fármaco para perder peso a quien pudiese pagarlo sin considerar nada. Ahora es que empezaremos a ver los efectos secundarios... Seguimos con la oda a la delgadez sin pensar consecuencias
The US health regulator on Monday informed patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. cnn.com/2026/11/09/health/gl…
Fabiola Valentina retweeted
The US health regulator on Monday informed patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. cnn.com/2026/11/09/health/gl…
